Synexa Life Sciences
Biotechnology Research • 
Leiden, South Holland, Netherlands • 101-200 Employees
Company overview
| Headquarters | 107 Regus Building 32 Mendelweg, Leiden Bioscience Park, Leiden, 2333CS, NL |
| Phone number | +31717601644 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biosimilars, Flow Cytometry, Proteomics, Bioanalysis, Translational Research, Liquid Biopsy, Immunoassays, Pharmacogenetics, Biomarker, Biomarker Analysis, Immunogenicity, Assay Development And Validation, Large Molecule Bioanalysis, Prototrials (Tm), Translational Immunology, Pk Analysis, Tk Analysis |
| Founded | 2003 |
| Employees | 101-200 |
| Socials |
Key Contacts at Synexa Life Sciences
Matthew Blow
Director Of Business Development
Nicola Hickson
Business Development Director
Justin Devine
Director And Chief Innovation Officer
Caroline Beltran
Scientific Director
Matt Goodwin
Account Director, Key Accounts
Justin Wildgoose
Director Of Business Development - Lc/Ms Services
Grace Loxley
Associate Director Business Development
Sally Hannam
Science Director
Nicholas Woudberg
Business Development Director
Timo Piironen
Scientific Director
Synexa Life Sciences Email Formats
Synexa Life Sciences uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@synexagroup.com), used 61.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@synexagroup.com | 61.4% |
{first initial}{last name} | jdoe@synexagroup.com | 37% |
About Synexa Life Sciences
Synexa Life Sciences is a leading provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of over 200 staff across 4 global laboratory locations; Cape Town, Manchester and Turku (Finland), we provide innovative solutions to support our customers achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genetic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.
Synexa Life Sciences revenue & valuation
| Annual revenue | $12,500,000 |
| Revenue per employee | $79,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $40,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Synexa Life Sciences has 88 employees across 13 departments.
Departments
Number of employees
Funding Data
Synexa Life Sciences has never raised funding before.
Synexa Life Sciences Tech Stack
Discover the technologies and tools that power Synexa Life Sciences's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
Security
Form builders
JavaScript libraries
JavaScript libraries
Analytics
Page builders
Video players
JavaScript libraries
CDN
United States
Canada
Guernsey
Italy
Australia
Frequently asked questions
4.8
40,000 users
